 |
인쇄하기
취소
|
Samjin’s clopidogrel drug takes on Plavix
Samjin Pharm is enjoying brisk sales of its blood-thinning agent, Platless (clopidogrel).
Sales of Samjin’s Platless reached 25.5 billion since its release in January 2007, making it one of the top-selling drugs in the country.
Its market share accounted for about 13 percent, gainging momentum.
Market watchers say Platless’s market share will further grow this year, challenging the No....
Sales of Samjin’s Platless reached 25.5 billion since its release in January 2007, making it one of the top-selling drugs in the country.
Its market share accounted for about 13 percent, gainging momentum.
Market watchers say Platless’s market share will further grow this year, challenging the No....
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.